STOCK TITAN

TD SYNNEX CORP SEC Filings

SNX NYSE

Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.

Rhea-AI Summary

TD SYNNEX (SNX) reported insider activity by its Chief Financial Officer on a Form 4. On 10/15/2025, the CFO received 5,739 shares of restricted stock at $0 under the 2020 Stock Incentive Plan. Per the disclosure, this award vests in equal thirds on each of the first three anniversaries of the grant date.

On the same day, a separate transaction covered 380 shares at $156.81. Following these transactions, the officer directly beneficially owned 17,945 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX (SNX) reported insider activity by its Chief Executive Officer and director on 10/15/2025. The filing lists a disposition coded “F” of 4,048 shares at $156.81 and an acquisition coded “A” of 22,957 shares at $0 under the 2020 Stock Incentive Plan. After these transactions, the reporting person directly owned 182,292 common shares.

The restricted stock award vests as to one-third of the shares on each of the first three anniversaries of the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX (SNX) filed a Form 144 notice for a proposed sale of up to 76,848 common shares on the NYSE through Goldman Sachs & Co. LLC, with an approximate sale date of 10/16/2025. The filing lists an aggregate market value of $11,912,208.48 for the shares.

The seller acquired 20,000 shares as RSU compensation on 06/30/2020 from the issuer, and 56,848 shares via stock options granted on 10/05/2021, indicated as a cashless exercise/same-day sale. Shares outstanding were 81,437,855; this is a baseline figure, not the amount being offered.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

TD SYNNEX (SNX) reported an insider transaction by its President, North America. On 10/10/2025, the officer sold 521 shares of common stock at $155.98 per share. Following the transaction, the reporting person beneficially owns 11,781 shares, held directly.

This filing is an administrative disclosure of insider activity and does not, by itself, indicate any change in company operations or strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Corp filing a Form 144 notifies a proposed sale of 521 common shares held as restricted stock. The shares were acquired from the issuer on 10/03/2024 and the filing lists an aggregate market value of $81,263.03. The proposed sale is through Morgan Stanley Smith Barney LLC on 10/10/2025 on the NYSE. The filer reports no securities sold in the past three months and attests they are not aware of undisclosed material adverse information about the issuer. The filing supplies acquisition and payment details and identifies the broker and timing for the planned transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TD SYNNEX Corp. director and officer Dennis Polk reported multiple transactions on 10/09/2025. He exercised employee stock options to acquire 14,320 shares at an exercise price of $90.52 and 3,180 shares at $106.35, increasing option-derived holdings shown in Table II. Concurrently he sold a total of 17,500 common shares in several transactions at weighted average prices in ranges reported between $155.27 and $157.26 (detailed in the filing). After these transactions the filing shows 31,117 shares owned directly and 81,660 shares held indirectly by trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TD SYNNEX Corporation disclosed supplemental indentures and forms for two series of senior notes as part of an 8-K filing dated October 10, 2025. The filing incorporates the original Indenture dated August 9, 2021 and adds a Sixth Supplemental Indenture and a Seventh Supplemental Indenture with Citibank, N.A. as trustee. The company included the form of 4.300% Senior Notes due 2029 and the form of 5.300% Senior Notes due 2035, along with an opinion and consent from Pillsbury Winthrop Shaw Pittman LLP. The filing also notes the interactive cover page XBRL tagging. This document outlines the legal instruments and note terms but does not state offering sizes, pricing, or use of proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Thompson Reyna, listed as President, North America and an officer of TD SYNNEX Corp (SNX), reported multiple dispositions of common stock on a Form 4. The filing shows a disposition of 58 shares on 10/07/2025 at a price of $158.65, and two additional dispositions on 10/08/2025 for 65 and 158 shares at a reported price of $0 for each line. The reported post-transaction beneficial ownership decreased from 12,525 shares to 12,302 shares following the transactions. The form includes an explanation stating: "Charitable donation of shares of common stock."

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share. After the sale he directly beneficially owns 31,117 shares and indirectly owns 81,660 shares through a trust, showing continued significant aggregate holdings while executing a small disposition. The form was signed by an attorney-in-fact on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TD SYNNEX Corp (SNX) Form 144 reports a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC on 10/09/2025, with an aggregate market value of $2,738,730.75. The filer states these shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists 81,437,855 shares outstanding, and shows recent disposals by the Polk Family Trust of 3,000 shares on each of 08/04/2025, 09/04/2025, and 10/06/2025 generating gross proceeds of $426,529.20, $445,486.80, and $477,258.30 respectively. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many TD SYNNEX (SNX) SEC filings are available on StockTitan?

StockTitan tracks 153 SEC filings for TD SYNNEX (SNX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TD SYNNEX (SNX)?

The most recent SEC filing for TD SYNNEX (SNX) was filed on October 16, 2025.